|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.31 USD | -0.77% |
|
+7.62% | +41.19% |
| Market Cap | 3.7B 3.23B 2.99B 2.8B 5.24B 349B 5.28B 35.44B 13.74B 172B 13.89B 13.59B 597B | P/E 2026 * |
-9.61x | P/E 2027 * | -9.71x |
|---|---|---|---|---|---|
| Enterprise Value | 3.03B 2.64B 2.44B 2.29B 4.29B 285B 4.31B 28.98B 11.23B 140B 11.36B 11.11B 488B | EV / Sales 2026 * |
73.8x | EV / Sales 2027 * | 26.8x |
| Free-Float |
90.08% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Denali Therapeutics Inc.
| 1 day | -0.77% | ||
| 1 week | +7.62% | ||
| Current month | +10.79% | ||
| 1 month | +28.71% | ||
| 3 months | +18.03% | ||
| 6 months | +38.34% | ||
| Current year | +41.19% |
| 1 week | 21.41 |  | 24.65 |
| 1 month | 18.18 | | 24.65 |
| Current year | 15.34 | | 24.65 |
| 1 year | 12.58 | | 24.65 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 79.7 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 2022-04-30 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 2015-07-31 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 2015-02-28 |
| Chairman | 66 | 2015-02-28 | |
Jay Flatley
BRD | Director/Board Member | 73 | 2015-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-02 | Free | Director | 25,634 | 0.0162% | ||
| 06-02 | Free | Director | 25,634 | 0.0162% | ||
| 06-02 | Free | Director | 25,634 | 0.0162% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.77% | +7.62% | +65.44% | -24.90% | 3.7B | |
| +1.44% | -1.25% | +63.52% | +114.88% | 55.19B | |
| +4.60% | +3.02% | +58.20% | +47.16% | 45.75B | |
| -1.44% | +0.39% | -12.94% | -19.24% | 22.98B | |
| -2.69% | -2.10% | -3.68% | +379.00% | 20.76B | |
| +3.22% | -0.84% | +27.88% | -34.00% | 16.26B | |
| +0.58% | +1.08% | +16.73% | -38.06% | 15.42B | |
| -1.01% | -2.30% | +27.42% | +171.92% | 13.05B | |
| +4.95% | +11.70% | +123.63% | +252.19% | 12.45B | |
| +3.07% | +0.14% | +29.37% | - | 12.37B | |
| Average | +1.19% | +3.10% | +39.56% | +94.33% | 21.79B | |
| Weighted average by Cap. | +1.59% | +1.63% | +41.33% | +97.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41M 35.75M 33.11M 30.99M 58.13M 3.87B 58.48M 393M 152M 1.9B 154M 151M 6.61B | 113M 98.68M 91.39M 85.55M 160M 10.68B 161M 1.08B 420M 5.26B 425M 416M 18.25B |
| Net income | -481M -420M -389M -364M -682M -45.4B -686M -4.61B -1.79B -22.35B -1.81B -1.77B -77.59B | -463M -404M -374M -350M -657M -43.73B -661M -4.44B -1.72B -21.52B -1.74B -1.7B -74.74B |
| Net Debt | -674M -588M -545M -510M -956M -63.64B -962M -6.46B -2.5B -31.32B -2.53B -2.48B -109B | -665M -580M -537M -502M -942M -62.72B -948M -6.37B -2.47B -30.87B -2.5B -2.44B -107B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 23.31 $ | -0.77% | 2,518,393 |
| 26-06-17 | 23.49 $ | +7.11% | 2,605,205 |
| 26-06-16 | 21.93 $ | -1.31% | 1,455,915 |
| 26-06-15 | 22.22 $ | +2.59% | 1,448,823 |
| 26-06-12 | 21.66 $ | +3.04% | 2,189,156 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNLI Stock
Select your edition
All financial news and data tailored to specific country editions
